KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case-control study.

PURPOSE: Renal cell carcinoma (RCC) has the potential for cure with surgery when diagnosed at an early stage. Kidney injury molecule-1 (KIM-1) has been shown to be elevated in the plasma of RCC patients. We aimed to test whether plasma KIM-1 could represent a means of detecting RCC prior to clinical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Scelo, Ghislaine, Muller, David C, Riboli, Elio, Johansson, Mattias, Cross, Amanda J, Vineis, Paolo, Tsilidis, Konstantinos K, Brennan, Paul, Boeing, Heiner, Peeters, Petra HM, Vermeulen, Roel C H, Overvad, Kim, Bueno-de-Mesquita, H. Bas, Severi, Gianluca, Perduca, Vittorio, Kvaskoff, Marina, Trichopoulou, Antonia, Vecchia, Carlo La, Karakatsani, Anna, Palli, Domenico, Sieri, Sabina, Panico, Salvatore, Weiderpass, Elisabete, Sandanger, Torkjel M, Nøst, Therese H, Agudo, Antonio, Quirós, J. Ramón, Rodríguez-Barranco, Miguel, Chirlaque, Maria-Dolores, Key, Timothy J, Khanna, Prateek, Bonventre, Joseph V., Sabbisetti, Venkata S., Bhatt, Rupal S.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239904/
https://ncbi.nlm.nih.gov/pubmed/30037816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-1496
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars